Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Axogen, Inc., UFP Technologies or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Axogen, Inc., UFP Technologies and Inc. compare based on key financial metrics to determine which better meets your investment needs.

About Axogen, Inc., UFP Technologies and Inc.

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft; and Avance Method, a technique to process Avance Nerve Graft from donated human peripheral nerve tissue. In addition, the company offers peripheral nerve tissue recovery and acquisition, and testing, as well as donor medical review and release, debridement and other processing steps, packaging, and sterilization. It provides its products to hospitals, surgery centers and military hospitals, calling on surgeons, including plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and certain oral and maxillofacial surgeons through independent in-country distributors. The company is headquartered in Alachua, Florida.

UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment protection and packaging for firearms, unmanned aerial vehicles/drones, weapon systems, electronic devices communications equipment, and tools and repair kits; cushion and protective packaging; acoustic and thermal insulation components for automotive, aerospace, consumer, and industrial; filtration for small engines, air conditioners, humidifiers, refrigerators, electronic air cleaners, forced air appliances and industrial compressors; fluid management; and seals and gaskets for automotive manufacturing chemical processing, building and construction applications. In addition, the company provides uniform and tactical gear, such as backpack straps and padding, uniform knee and elbow pads, duty belts, holsters, and helmet padding and others; sports and leisure including custom helmet linings, athletic braces, and shoe insoles; and trim and structural components, consist of load floors, sunshades, package trays, back panel, and seat backs. The company serves the medical, aerospace and defence, automotive, consumer, electronics, and industrial markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

Latest Health Care Equipment & Supplies and Axogen, Inc., UFP Technologies, Inc. Stock News

As of July 30, 2026, Axogen, Inc. had a $2.2 billion market capitalization, compared to the Health Care Equipment & Supplies median of $334.8 million. Axogen, Inc.’s stock is up 26.5% in 2026, up 4.9% in the previous five trading days and up 207.89% in the past year.

Currently, Axogen, Inc. does not have a price-earnings ratio. Axogen, Inc.’s trailing 12-month revenue is $238.1 million with a -13.4% net profit margin. Year-over-year quarterly sales growth most recently was 26.5%. Analysts expect adjusted earnings to reach $0.440 per share for the current fiscal year. Axogen, Inc. does not currently pay a dividend.

As of July 30, 2026, UFP Technologies, Inc. had a $2.0 billion market cap, putting it in the 54th percentile of all stocks. UFP Technologies, Inc.’s stock is up 14.2% in 2026, up 6.9% in the previous five trading days and up 7.41% in the past year.

Currently, UFP Technologies, Inc.’s price-earnings ratio is 29.1. UFP Technologies, Inc.’s trailing 12-month revenue is $608.9 million with a 11.3% net profit margin. Year-over-year quarterly sales growth most recently was 4.1%. Analysts expect adjusted earnings to reach $10.385 per share for the current fiscal year. UFP Technologies, Inc. does not currently pay a dividend.

How We Compare Axogen, Inc., UFP Technologies and Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Axogen, Inc., UFP Technologies and Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Axogen, Inc., UFP Technologies and Inc. Stock Value Grades

Company	Ticker	Value
Axogen, Inc.	AXGN	F
UFP Technologies, Inc.	UFPT	D

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.

Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.

Axogen, Inc. has a Value Score of 2, which is Ultra Expensive. UFP Technologies, Inc. has a Value Score of 24, which is Expensive.

The Value Stock Winner: No Clear Winner

Neither Axogen, Inc., UFP Technologies or Inc. has a high enough value grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolio. It’s important to look at a wide range of financial metrics in order to determine if Axogen, Inc., UFP Technologies or Inc. is the better investment when it comes to value.

Axogen, Inc., UFP Technologies and Inc.’s Momentum Grades

Company	Ticker	Momentum
Axogen, Inc.	AXGN	A
UFP Technologies, Inc.	UFPT	B

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Axogen, Inc. has a Momentum Score of 94, which is Very Strong. UFP Technologies, Inc. has a Momentum Score of 75, which is Strong.

The Momentum Grade Winner: Axogen, Inc.

As you can clearly see from the Momentum Grade breakdown above, Axogen, Inc. is considered to have stronger momentum compared to UFP Technologies, Inc.. For those specifically looking for companies that have stronger momentum compared to other companies in the same industry, Axogen, Inc. could be a good stock to invest in. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Axogen, Inc., UFP Technologies and Inc.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Axogen, Inc.	AXGN	F
UFP Technologies, Inc.	UFPT	C

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Axogen, Inc. has a Earnings Estimate Score of 20, which is Very Negative. UFP Technologies, Inc. has a Earnings Estimate Score of 59, which is Neutral.

The Earnings Estimate Revisions Stock Winner: No Clear Winner

Neither Axogen, Inc., UFP Technologies or Inc. has an Earnings Estimate Revisions Grade that could be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Axogen, Inc., UFP Technologies or Inc. is the better investment when it comes to estimate revisions.

Other Axogen, Inc., UFP Technologies and Inc. Grades

In addition to Momentum, Estimate Revisions and Value, A+ Investor also provides grades for Growth and Quality.

Growth investing builds on the idea that stocks of companies exhibiting strong, consistent and prolonged growth outperform those of slower-growth companies. AAII measures growth through consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations.

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Axogen, Inc., UFP Technologies and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Axogen, Inc., UFP Technologies or Inc. Stock?

Overall, Axogen, Inc. stock has a Value Score of 2, Momentum Score of 94 and Estimate Revisions Score of 20.

UFP Technologies, Inc. stock has a Value Score of 24, Momentum Score of 75 and Estimate Revisions Score of 59.

Comparing Axogen, Inc., UFP Technologies and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.